{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:49:52Z","timestamp":1793213392464,"version":"4.5.0"},"reference-count":101,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the world. It is linked mainly to insulin resistance and metabolic syndrome including obesity and dyslipidemia. In addition, various endocrine dysfunctions including polycystic ovary syndrome (PCOS) and hypogonadism are involved in the development and progression of NAFLD. We need to know the disease pathophysiology more accurately due to the heterogeneity of clinical presentation of fatty liver disease. The liver is the major metabolic organ with sexual dimorphism. Sexual dimorphism is associated not only with behavioral differences between men and women, but also with physiological differences reflected in liver metabolism. In men, normal androgen levels prevent hepatic fat accumulation, whereas androgen deficiency induce hepatic steatosis. In women, higher androgens can increase the risk of NAFLD in PCOS. Sex hormone binding globulin (SHBG) is involved in androgen regulation. Recently, SHBG may be reported as a surrogate marker for NAFLD. Therefore, this review will focus on the mechanism of androgen dysfunction in the regulation of hepatic metabolism, the risk of developing NAFLD, and the potential role of SHBG in the course of NAFLD.; Keywords: Non-alcoholic fatty liver disease, insulin resistance, sexual dimorphism, androgen, sex hormone binding globulin<\/jats:p>","DOI":"10.3389\/fendo.2022.1053709","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T05:23:09Z","timestamp":1669094589000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Androgen dysfunction in non-alcoholic fatty liver disease: Role of sex hormone binding globulin"],"prefix":"10.3389","volume":"13","author":[{"given":"Myeong Jun","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.06.008","article-title":"Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease","volume":"69","author":"Lebeaupin","year":"2018","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1217611110","article-title":"Membrane lipid saturation activates endoplasmic reticulum unfolded protein response transducers through their transmembrane domains","volume":"110","author":"Volmer","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1146\/annurev.ph.45.030183.000345","article-title":"Sexual dimorphism in the liver","volume":"45","author":"Roy","year":"1983","journal-title":"Annu Rev Physiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1101\/gr.5217506","article-title":"Tissue-specific expression and regulation of sexually dimorphic genes in mice","volume":"16","author":"Yang","year":"2006","journal-title":"Genome Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.572490","article-title":"Non-alcoholic fatty liver disease as a canonical example of metabolic inflammatory-based liver disease showing a sex-specific prevalence: Relevance of estrogen signaling","volume":"11","author":"Della Torre","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrendo.2013.203","article-title":"Energy metabolism and fertility: a balance preserved for female health","volume":"10","author":"Della Torre","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.phrs.2017.03.014","article-title":"Gender differences in liver disease and the drug-dose gender gap","volume":"120","author":"Buzzetti","year":"2017","journal-title":"Pharmacol Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000184787","article-title":"Sex hormone-binding globulin: gene organization and structure\/function analyses","volume":"45","author":"Hammond","year":"1996","journal-title":"Horm Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107401","article-title":"The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease","volume":"203","author":"Song","year":"2019","journal-title":"Pharmacol Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/916585","article-title":"Estrogen: an emerging regulator of insulin action and mitochondrial function","volume":"2015","author":"Gupte","year":"2015","journal-title":"J Diabetes Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1159\/000485999","article-title":"Metabolic syndrome in Male hypogonadism","volume":"49","author":"Rastrelli","year":"2018","journal-title":"Front Horm Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","article-title":"Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies","volume":"35","author":"Sanchez-Garrido","year":"2020","journal-title":"Mol Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/294278","article-title":"Sex hormones and their receptors regulate liver energy homeostasis","volume":"2015","author":"Shen","year":"2015","journal-title":"Int J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M028969","article-title":"Differential effects of estrogen\/androgen on the prevention of nonalcoholic fatty liver disease in the male rat","volume":"54","author":"Zhang","year":"2013","journal-title":"J Lipid Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"role estrogens Ann Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo12040298","article-title":"Nonalcoholic fatty liver disease and endocrine axes-a scoping review","volume":"12","author":"Von-Hafe","year":"2022","journal-title":"Metabolites"},{"key":"B22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00374","article-title":"Liver and steroid hormones-can a touch of p53 make a difference","volume":"10","author":"Charni-Natan","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1530\/joe-12-0455","article-title":"Testosterone: a metabolic hormone in health and disease","volume":"217","author":"Kelly","year":"2013","journal-title":"J Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1530\/eje-17-0124","article-title":"MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease","volume":"177","author":"Schiffer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B27","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/eje-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European society of endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep380","article-title":"Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"25","author":"Vassilatou","year":"2010","journal-title":"Hum Reprod"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew076","article-title":"Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome","volume":"31","author":"Macut","year":"2016","journal-title":"Hum Reprod"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0870","article-title":"Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy","volume":"94","author":"Cussons","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-00408-y","article-title":"Therapeutic pipeline in nonalcoholic steatohepatitis","volume":"18","author":"Vuppalanchi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e23235","DOI":"10.5812\/hepatmon.23235","article-title":"Are women with polycystic ovarian syndrome at a high risk of non-alcoholic fatty liver disease; a meta-analysis","volume":"14","author":"Ramezani-Binabaj","year":"2014","journal-title":"Hepat Mon"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i26.8351","article-title":"Nonalcoholic fatty liver disease and polycystic ovary syndrome","volume":"20","author":"Vassilatou","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186136","article-title":"Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS","volume":"12","author":"Petta","year":"2017","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.16-3-262","article-title":"Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance","volume":"16","author":"Barber","year":"2016","journal-title":"Clin Med (Lond)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/15.6.1266","article-title":"Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome","volume":"15","author":"Morin-Papunen","year":"2000","journal-title":"Hum Reprod"},{"key":"B38","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1210\/edrv.18.6.0318","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.11.7593430","article-title":"Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1","volume":"80","author":"Yki-J\u00e4rvinen","year":"1995","journal-title":"vivo J Clin Endocrinol Metab"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ncpendmet0637","article-title":"The reproductive phenotype in polycystic ovary syndrome","volume":"3","author":"Chang","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: An unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PloS Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-133","article-title":"Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS)","volume":"11","author":"Baranova","year":"2013","journal-title":"J Transl Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M414231200","article-title":"Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes","volume":"280","author":"Xu","year":"2005","journal-title":"J Biol Chem"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S362424","article-title":"Current perspectives on nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"15","author":"Wang","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/joe-21-0040","article-title":"DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice","volume":"250","author":"Seidu","year":"2021","journal-title":"J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2021.105829","article-title":"Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats","volume":"208","author":"Cui","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24477","article-title":"Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver","volume":"9","author":"Zhang","year":"2018","journal-title":"Oncotarget"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.2.3722","article-title":"Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome","volume":"82","author":"Ehrmann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04467.x","article-title":"Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis","volume":"32","author":"Rakoski","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial","volume":"20","author":"Fr\u00f8ssing","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)61126-5","article-title":"Male Hypogonadism","volume":"383","author":"Basaria","year":"2014","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","first-page":"83","DOI":"10.17925\/ee.2019.15.2.83","article-title":"Male Obesity-related secondary hypogonadism - pathophysiology, clinical implications and management","volume":"15","author":"Fernandez","year":"2019","journal-title":"Eur Endocrinol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12135","article-title":"Prevalence of male secondary hypogonadism in moderate to severe obesity and its relationship with insulin resistance and excess body weight","volume":"4","author":"Calder\u00f3n","year":"2016","journal-title":"Andrology"},{"key":"B56","article-title":"High prevalence of hypogonadotropic hypogonadism in men referred for obesity treatment","volume":"66","author":"Hofstra","year":"2008","journal-title":"Neth J Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cgh.2019.11.053","article-title":"Low testosterone is associated with nonalcoholic steatohepatitis and fibrosis severity in men","volume":"19","author":"Sarkar","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1326","article-title":"Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men","volume":"91","author":"Kupelian","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i39.11053","article-title":"Endocrine causes of nonalcoholic fatty liver disease","volume":"21","author":"Marino","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.steroids.2018.04.004","article-title":"Possible mechanisms underlying fatty liver in a rat model of male hypogonadism: A protective role for testosterone","volume":"135","author":"Sakr","year":"2018","journal-title":"Steroids"},{"key":"B61","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1530\/ec-20-0490","article-title":"Pathophysiology of NASH in endocrine diseases","volume":"10","author":"Gariani","year":"2021","journal-title":"Endocr Connect"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1510415","article-title":"Effects of androgen substitution on lipid profile in the adult and aging hypogonadal male","volume":"151","author":"Schleich","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2006.75","article-title":"Dihydrotestosterone treatment results in obesity and altered lipid metabolism in orchidectomized mice","volume":"14","author":"Mov\u00e9rare-Skrtic","year":"2006","journal-title":"Obes (Silver Spring)"},{"key":"B64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cca.2008.09.011","article-title":"Sex steroids enhance insulin receptors and glucose oxidation in Chang liver cells","volume":"399","author":"Parthasarathy","year":"2009","journal-title":"Clin Chim Acta"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101521200","article-title":"Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action","volume":"277","author":"Aguirre","year":"2002","journal-title":"J Biol Chem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11010-011-0737-1","article-title":"Sex steroids influence glucose oxidation through modulation of insulin receptor expression and IRS-1 serine phosphorylation in target tissues of adult male rat","volume":"352","author":"Muthusamy","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.05.010","article-title":"Sex steroids deficiency impairs glucose transporter 4 expression and its translocation through defective akt phosphorylation in target tissues of adult male rat","volume":"58","author":"Muthusamy","year":"2009","journal-title":"Metabolism"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a008832","article-title":"Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men","volume":"143","author":"Haffner","year":"1996","journal-title":"MRFIT Res Group Multiple Risk Factor Intervention Trial Am J Epidemiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12633","article-title":"Testosterone a key factor in gender related metabolic syndrome","volume":"19","author":"Bianchi","year":"2018","journal-title":"Obes Rev"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(92)90012-f","article-title":"Lower endogenous androgens predict central adiposity in men","volume":"2","author":"Khaw","year":"1992","journal-title":"Ann Epidemiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0401","article-title":"Association of specific symptoms and metabolic risks with serum testosterone in older men","volume":"91","author":"Zitzmann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0980-9","article-title":"The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men","volume":"46","author":"Zitzmann","year":"2003","journal-title":"Diabetologia"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.4.1000","article-title":"Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion","volume":"54","author":"Fan","year":"2005","journal-title":"Diabetes"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1717","article-title":"Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor","volume":"54","author":"Lin","year":"2005","journal-title":"Diabetes"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1210\/en.2003-0741","article-title":"Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1\/2 pluripotent cells through an androgen receptor-mediated pathway","volume":"144","author":"Singh","year":"2003","journal-title":"Endocrinology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40842-020-00106-3","article-title":"SHBG and total testosterone levels in men with adult onset hypogonadism: what are we overlooking","volume":"6","author":"Winters","year":"2020","journal-title":"Clin Diabetes Endocrinol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1788","article-title":"Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men","volume":"33","author":"Li","year":"2010","journal-title":"Diabetes Care"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12319","article-title":"Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study","volume":"68","author":"Traish","year":"2014","journal-title":"Int J Clin Pract"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1097\/med.0000000000000086","article-title":"Testosterone and weight loss: the evidence","volume":"21","author":"Traish","year":"2014","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-64-4-825","article-title":"Sex hormone-binding globulin secretion by human hepatocarcinoma cells is increased by both estrogens and androgens","volume":"64","author":"Lee","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1210\/jcem-53-1-58","article-title":"Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma","volume":"53","author":"Dunn","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-1-83","article-title":"A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome","volume":"72","author":"Nestler","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.44","article-title":"Testosterone levels in pre-menopausal women are associated with nonalcoholic fatty liver disease in midlife","volume":"112","author":"Sarkar","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-0760(99)00070-9","article-title":"Sex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane","volume":"69","author":"Rosner","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.06.032","article-title":"Role of endocytosis in cellular uptake of sex steroids","volume":"122","author":"Hammes","year":"2005","journal-title":"Cell"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-0760(99)00068-0","article-title":"Sex hormone-binding globulin, its membrane receptor, and breast cancer: a new approach to the modulation of estradiol action in neoplastic cells","volume":"69","author":"Fortunati","year":"1999","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1750113","article-title":"Sex hormone-binding globulin is synthesized in target cells","volume":"175","author":"Kahn","year":"2002","journal-title":"J Endocrinol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1677\/jme-09-0025","article-title":"Thyroid hormones act indirectly to increase sex hormone-binding globulin production by liver via hepatocyte nuclear factor-4alpha","volume":"43","author":"Selva","year":"2009","journal-title":"J Mol Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.09.020","article-title":"Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome","volume":"316","author":"Pugeat","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1210\/en.2008-1289","article-title":"Peroxisome-proliferator receptor gamma represses hepatic sex hormone-binding globulin expression","volume":"150","author":"Selva","year":"2009","journal-title":"Endocrinology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00740","article-title":"Sex hormone-binding globulin expression correlates with acetyl-coenzyme a carboxylase and triglyceride content in human liver","volume":"104","author":"S\u00e1ez-L\u00f3pez","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1411474","article-title":"SHBG expression is correlated with PI3K\/AKT pathway activity in a cellular model of human insulin resistance","volume":"34","author":"Feng","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113261","article-title":"Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment","volume":"153","author":"Bourebaba","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20092358","article-title":"Adipose tissue dysfunction as determinant of obesity-associated metabolic complications","volume":"20","author":"Longo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1321","article-title":"Molecular mechanism of TNF\u03b1-induced down-regulation of SHBG expression","volume":"26","author":"Sim\u00f3","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1210\/me.2012-1152","article-title":"IL1\u03b2 down-regulation of sex hormone-binding globulin production by decreasing HNF-4\u03b1 via MEK-1\/2 and JNK MAPK pathways","volume":"26","author":"Sim\u00f3","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1072","article-title":"Adiponectin upregulates SHBG production: molecular mechanisms and potential implications","volume":"155","author":"Sim\u00f3","year":"2014","journal-title":"Endocrinology"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.5604\/16652681.1235481","article-title":"Testosterone, sex hormone-binding globulin and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Jaruvongvanich","year":"2017","journal-title":"Ann Hepatol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3062319","article-title":"Protective effect of sex hormone-binding globulin against metabolic syndrome: In vitro evidence showing anti-inflammatory and lipolytic effects on adipocytes and macrophages","volume":"2018","author":"Yamazaki","year":"2018","journal-title":"Mediators Inflamm"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa574","article-title":"Sex hormone relations to histologic severity of pediatric nonalcoholic fatty liver disease","volume":"105","author":"Mueller","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1053709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T05:23:12Z","timestamp":1669094592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.1053709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":101,"alternative-id":["10.3389\/fendo.2022.1053709"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.1053709","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"article-number":"1053709"}}